Literature DB >> 29076134

Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model.

Yushi Qiu1, Zhimin Li1, Frederic Pouzoulet2, Prakash Vishnu3, John A Copland1, Keith L Knutson4, Carole Soussain2, Han W Tun1,3.   

Abstract

Entities:  

Keywords:  CD274 (PD-L1); PDCD1LG2 (PD-L2); anti-PDCD1 (anti-PD1); primary central nervous system lymphoma (PCNSL); survival

Mesh：

Substances：

Year:  2017        PMID： 29076134     DOI： 10.1111/bjh.15009

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma.

Authors:  Han W Tun; Patrick B Johnston; Lisa M DeAngelis; Pamela J Atherton; Levi D Pederson; Patricia A Koenig; Craig B Reeder; Antonio M Padula Omuro; David Schiff; Brian O'Neill; Jose Pulido; Kurt A Jaeckle; Christian Grommes; Thomas E Witzig
Journal:  Blood       Date:  2018-09-27       Impact factor: 22.113

Review 2.  Introduction of novel agents in the treatment of primary CNS lymphoma.

Authors:  Christian Grommes; Lakshmi Nayak; Han W Tun; Tracy T Batchelor
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

3.  Systemic Relapse in a Young Adult Patient with Primary CNS Diffuse Large B-Cell Lymphoma.

Authors:  Adam Khorasanchi; Zachary Benson; Misty Hall; Nelya Ebadirad; Mohammad H Gharavi; Patrick Willard; Miranda Chimzar; John McKay; Gary Simmons; Victor Yazbeck
Journal:  Case Rep Hematol       Date:  2022-06-21

4.  Molecular characteristics of immunocytes infiltration in primary central nervous system lymphoma.

Authors:  Linyun Zhang; Fei Sun; Xiaona Lu; Xiaotong Wang; Jie Wang; Jun Li; Yingsong Xu; Daqing Kou; Hongtao Lv; Bin Don
Journal:  Front Genet       Date:  2022-08-17       Impact factor: 4.772

5.  Molecular subtypes, clinical significance, and tumor immune landscape of angiogenesis-related genes in ovarian cancer.

Authors:  Haixia Tang; Jingsong Shan; Juan Liu; Xuehai Wang; Fengxu Wang; Suping Han; Xinyuan Zhao; Jinxiu Wang
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

6.  Primary CNS lymphoma commonly expresses immune response biomarkers.

Authors:  Alexander Ou; Ashley Sumrall; Surasak Phuphanich; David Spetzler; Zoran Gatalica; Joanne Xiu; Sharon Michelhaugh; Andrew Brenner; Manjari Pandey; Santosh Kesari; W Michael Korn; Sandeep Mittal; Jason Westin; Amy B Heimberger
Journal:  Neurooncol Adv       Date:  2020-02-19

7.  Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition.

Authors:  Isabel Jiménez; Júlia Carabia; Francesc Bosch; Marta Crespo; Sabela Bobillo; Carles Palacio; Pau Abrisqueta; Carlota Pagès; Juan C Nieto; Josep Castellví; Francisco Martínez-Ricarte; Lourdes Escoda; Cristóbal Perla; Dennis H Céspedes Torrez; Joan Boix; Noelia Purroy; Lluís Puigdefàbregas; Joan Seoane
Journal:  J Neurooncol       Date:  2020-07-20       Impact factor: 4.130
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.